Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0441db0baf216a781fbefeb879b742f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc794e69efac361478cd7088f1a67e7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7422cace09ae489371987516b5d18876 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2006-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaa9bc416328f35c722c98eb2017cabb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ccde43568aa09e33fef538fa82912f2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_059e51e83caeeeefdffdceeb7389b56b |
publicationDate |
2006-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2006073154-A1 |
titleOfInvention |
Medicinal composition and process for producing the same |
abstract |
A production process which comprises (1) a step in which a raw liquid containing a drug is prepared so that the drug is contained in an amount which exceeds the saturation amount thereof as determined at the temperature to be used in a treatment with a high-pressure homogenizer and is less than the amount which is larger than that drug saturation amount by 1 g per 100 mL of a solvent and that the raw liquid contains substantially no surface modifiers; and (2) a step in which the raw liquid is treated with a high-pressure homogenizer at a pressure of 15-300 Mpa while regulating the temperature of the raw liquid so as to exceed the solidifying point of the liquid and be lower than the boiling point thereof. By the process, fine solid particles of a drug and a medicinal composition containing the fine solid drug particles can be obtained. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107510600-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017019845-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013501051-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013525338-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101793656-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011506400-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9956144-B2 |
priorityDate |
2005-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |